| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 4 | 98 | 11 | 113 |
| - | - | - | - | - | - | - | 2 | 14 | 3 | 19 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| 100 | 4,334 | 37 | - | - | - | - | 4,471 |
| 3 | 577 | 9 | - | - | - | - | 589 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LO(L) | 4,471 | 97.1% | -2.92 | 589 | 96.9% |
| ME(L) | 113 | 2.5% | -2.57 | 19 | 3.1% |
| Optic-unspecified(L) | 19 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Pm7_Li28 | % In | CV |
|---|---|---|---|---|---|
| Tm3 (L) | 274 | ACh | 1,874 | 42.2% | 0.5 |
| Tm2 (L) | 245 | ACh | 1,803 | 40.6% | 0.6 |
| MeLo13 (L) | 18 | Glu | 184 | 4.1% | 0.5 |
| TmY14 (L) | 75 | unc | 169 | 3.8% | 0.6 |
| MeLo14 (L) | 12 | Glu | 69 | 1.6% | 0.7 |
| T2 (L) | 31 | ACh | 43 | 1.0% | 0.4 |
| Li38 (R) | 1 | GABA | 39 | 0.9% | 0.0 |
| OLVC3 (R) | 1 | ACh | 38 | 0.9% | 0.0 |
| TmY3 (L) | 19 | ACh | 31 | 0.7% | 0.5 |
| MeVPOL1 (R) | 1 | ACh | 28 | 0.6% | 0.0 |
| Tm4 (L) | 16 | ACh | 21 | 0.5% | 0.4 |
| TmY5a (L) | 18 | Glu | 21 | 0.5% | 0.3 |
| Li17 (L) | 5 | GABA | 19 | 0.4% | 0.7 |
| MeVC25 (L) | 1 | Glu | 15 | 0.3% | 0.0 |
| Pm3 (L) | 3 | GABA | 11 | 0.2% | 1.0 |
| TmY15 (L) | 4 | GABA | 6 | 0.1% | 0.3 |
| Li28 (L) | 2 | GABA | 5 | 0.1% | 0.6 |
| Li29 (L) | 3 | GABA | 5 | 0.1% | 0.6 |
| MeVPLo1 (L) | 2 | Glu | 5 | 0.1% | 0.2 |
| TmY19a (L) | 5 | GABA | 5 | 0.1% | 0.0 |
| Mi1 (L) | 2 | ACh | 4 | 0.1% | 0.5 |
| Li25 (L) | 3 | GABA | 4 | 0.1% | 0.4 |
| Li15 (L) | 1 | GABA | 3 | 0.1% | 0.0 |
| LC14a-1 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| T5a (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| Tm23 (L) | 3 | GABA | 3 | 0.1% | 0.0 |
| MeLo9 (L) | 1 | Glu | 2 | 0.0% | 0.0 |
| LC23 (L) | 1 | ACh | 2 | 0.0% | 0.0 |
| LT11 (L) | 1 | GABA | 2 | 0.0% | 0.0 |
| OA-AL2i2 (L) | 1 | OA | 2 | 0.0% | 0.0 |
| T5d (L) | 2 | ACh | 2 | 0.0% | 0.0 |
| MeLo8 (L) | 2 | GABA | 2 | 0.0% | 0.0 |
| MeLo11 (L) | 2 | Glu | 2 | 0.0% | 0.0 |
| Tm9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY18 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| T5b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| T5c (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi4 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY13 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LLPC2 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LC4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LoVC21 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| DNc02 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| LoVC16 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-AL2i1 (L) | 1 | unc | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Pm7_Li28 | % Out | CV |
|---|---|---|---|---|---|
| LC4 (L) | 33 | ACh | 454 | 33.4% | 1.0 |
| Tm2 (L) | 162 | ACh | 298 | 21.9% | 0.6 |
| LC23 (L) | 5 | ACh | 115 | 8.4% | 0.5 |
| LC12 (L) | 56 | ACh | 110 | 8.1% | 0.6 |
| MeLo12 (L) | 12 | Glu | 57 | 4.2% | 0.7 |
| Tm3 (L) | 43 | ACh | 49 | 3.6% | 0.4 |
| Li15 (L) | 10 | GABA | 41 | 3.0% | 0.6 |
| T2 (L) | 30 | ACh | 40 | 2.9% | 0.4 |
| LT11 (L) | 1 | GABA | 36 | 2.6% | 0.0 |
| T5b (L) | 19 | ACh | 21 | 1.5% | 0.3 |
| MeLo10 (L) | 9 | Glu | 16 | 1.2% | 0.6 |
| TmY3 (L) | 12 | ACh | 14 | 1.0% | 0.3 |
| LPLC1 (L) | 6 | ACh | 13 | 1.0% | 0.8 |
| TmY5a (L) | 11 | Glu | 11 | 0.8% | 0.0 |
| LLPC2 (L) | 7 | ACh | 10 | 0.7% | 0.5 |
| TmY14 (L) | 7 | unc | 9 | 0.7% | 0.5 |
| LC31a (L) | 2 | ACh | 8 | 0.6% | 0.8 |
| Li38 (R) | 1 | GABA | 7 | 0.5% | 0.0 |
| Pm3 (L) | 2 | GABA | 6 | 0.4% | 0.0 |
| MeLo14 (L) | 4 | Glu | 6 | 0.4% | 0.6 |
| Li26 (L) | 1 | GABA | 3 | 0.2% | 0.0 |
| TmY19a (L) | 2 | GABA | 3 | 0.2% | 0.3 |
| Li25 (L) | 2 | GABA | 3 | 0.2% | 0.3 |
| Li29 (L) | 2 | GABA | 3 | 0.2% | 0.3 |
| Tm23 (L) | 3 | GABA | 3 | 0.2% | 0.0 |
| MeLo13 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Li17 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm6 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Pm10 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| TmY15 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LPLC4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| T3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| T5c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| T4b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| TmY_unclear (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| T5d (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y14 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| TmY13 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| TmY9a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm24 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lawf2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm37 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Li28 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LoVC21 (R) | 1 | GABA | 1 | 0.1% | 0.0 |